275
Views
13
CrossRef citations to date
0
Altmetric
Expert Opinion

Treatable Traits in COPD – A Proposed Approach

, ORCID Icon, ORCID Icon, , &
Pages 3167-3182 | Published online: 18 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Mario Cazzola, Paola Rogliani & Francesco Blasi. (2023) Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1959-1964.
Read now
Donald A Mahler, Henrik Watz, Rachel Emerson-Stadler, John Ritz, Asparuh Gardev, Asif Shaikh & M Bradley Drummond. (2023) Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1729-1740.
Read now
Richard Kraemer, Fabian Gardin, Hans-Jürgen Smith, Florent Baty, Jürg Barandun, Andreas Piecyk, Stefan Minder, Jörg Salomon, Martin Frey, Martin H Brutsche & Heinrich Matthys. (2022) Functional Predictors Discriminating Asthma–COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD). International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2723-2743.
Read now
Roland Buhl, Thomas Wilke, Nils Picker, Olaf Schmidt, Marlene Hechtner, Anke Kondla, Ulf Maywald & Claus F Vogelmeier. (2022) Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2355-2367.
Read now
Miguel Angel Martinez-Garcia & Marc Miravitlles. (2022) The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 621-630.
Read now

Articles from other publishers (8)

Stanley M. H. Chan, Kurt Brassington, Suleman Abdullah Almerdasi, Aleksandar Dobric, Simone N. De Luca, Madison Coward‐Smith, Hao Wang, Kevin Mou, Alina Akhtar, Rana Abdullah Alateeq, Wei Wang, Huei Jiunn Seow, Stavros Selemidis, Steven Bozinovski & Ross Vlahos. (2023) Inhibition of oxidative stress by apocynin attenuated chronic obstructive pulmonary disease progression and vascular injury by cigarette smoke exposure. British Journal of Pharmacology 180:15, pages 2018-2034.
Crossref
Iseul Yu, Se Hwa Hong, Min-Seok Chang, Seok Jeong Lee, Suk Joong Yong, Won-Yeon Lee, Sang-Ha Kim & Ji-Ho Lee. (2023) Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Pulmonary Disease in Chronic Obstructive Pulmonary Disease: Findings from a Nationwide Population-Based Study. Journal of Personalized Medicine 13:7, pages 1088.
Crossref
Thomas Melzer & Kathrin Kahnert. (2023) Nach COPD-Exazerbation: Patienten mit Schrittzähler anspornen. Pneumo News 15:3, pages 19-21.
Crossref
Alvar Agusti, Peter G. Gibson & Vanessa M. McDonald. (2023) Treatable Traits in Airway Disease: From Theory to Practice. The Journal of Allergy and Clinical Immunology: In Practice 11:3, pages 713-723.
Crossref
Sara Souto-Miranda, Vânia Rocha, Maria Aurora Mendes, Paula Simão, Vitória Martins, Martijn A. Spruit & Alda Marques. (2023) The presence of extra-pulmonary treatable traits increases the likelihood of responding to pulmonary rehabilitation. Respiratory Medicine 206, pages 107086.
Crossref
Natalia Przysucha, Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Proboszcz, Patrycja Nejman-Gryz, Magdalena Paplińska-Goryca, Barbara Dymek, Agnieszka Zagozdzon & Rafał Krenke. (2022) The Role of Chitinases in Chronic Airway Inflammation Associated with Tobacco Smoke Exposure. Cells 11:23, pages 3765.
Crossref
Lin Feng, Jiachen Li, Xiaoshuang Lv, Shuilian Chu, Changwei Li, Ruiyuan Zhang, Xi Cao & Lirong Liang. (2022) Temporal trends in anxiety and depression prevalence and their association with adverse outcomes in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease in Beijing, China, from 2004 to 2020. Frontiers in Psychiatry 13.
Crossref
Balazs Antus & Imre Barta. (2022) Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation. Biomedicines 10:9, pages 2128.
Crossref